Literature DB >> 22839111

T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.

Surekha Tony1, Shahina Daar, Mohamed Elshinawy, Shoaib Al-Zadjaly, Murtadha Al-Khabori, Yasser Wali.   

Abstract

Nontransfused patients with thalassemia intermedia (TI) accumulate iron due to increased gastrointestinal absorption of iron. Recent studies using T2* MRI revealed that serum ferritin does not reflect the severity of iron overload in nontransfused TI patients. We evaluated the iron overload status in TI children on monthly transfusion. Based on serum ferritin levels, 11 such patients (mean age 13.18 ± 4.09 years), were classified into two groups, group 1 (six patients) and group 2 (five patients) with serum ferritin levels below and above 1000 ng/mL, respectively. T2* MRI assessments were done for evaluation of hepatic and cardiac iron status. Group 1 and group 2 had mean serum ferritin levels of 817.300 ± 244.690 ng/mL and 1983.80 ± 662.862 ng/mL, respectively (P = .003). T2* MRI showed comparable moderate to severe hepatic iron overload status in both. None of the patients had myocardial iron deposition. We conclude that serum ferritin does not reflect the hepatic iron overload status in our patients with TI on regular transfusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22839111     DOI: 10.3109/08880018.2012.708891

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  9 in total

1.  Single Breath-Hold Physiotherapy Technique: Effective tool for T2* magnetic resonance imaging in young patients with thalassaemia major.

Authors:  Surekha T Mevada; Najma Al-Mahruqi; Ismail El-Beshlawi; Mohamed El-Shinawy; Mathew Zachariah; Abdul H Al-Rawas; Shahina Daar; Yasser Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

2.  Cardio-protective effect of regular transfusion in children with non-transfusion dependent thalassemia (NTDT): A cohort study.

Authors:  Khalfan Al Senaidi; Surekha Maveda; Niranjan Joshi; Hanan Nazir; Mohamed Elshinawy; Shoaib Al Zadjali; Abdulhakim Al Rawas; Islam Elghamry; Yasser Wali; Doaa Khater
Journal:  Acta Biomed       Date:  2022-05-11

Review 3.  Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm.

Authors:  Julie A Jaffray; W Beau Mitchell; Merlin Nithya Gnanapragasam; Surya V Seshan; Xinhuo Guo; Connie M Westhoff; James J Bieker; Deepa Manwani
Journal:  Blood Cells Mol Dis       Date:  2013-03-20       Impact factor: 3.039

4.  Heterogeneity of myocardial iron distribution in response to chelation therapy in patients with transfusion-dependent anemias.

Authors:  Kate Hanneman; Vikram M Raju; Hadas Moshonov; Richard Ward; Bernd J Wintersperger; Andrew M Crean; Heather Ross; Elsie T Nguyen
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-04       Impact factor: 2.357

5.  Serum ferritin levels and irregular use of iron chelators predict liver iron load in patients with major beta thalassemia: a cross-sectional study.

Authors:  Soheila Sobhani; Farzaneh Rahmani; Maryam Rahmani; Marzieh Askari; Farzad Kompani
Journal:  Croat Med J       Date:  2019-10-31       Impact factor: 1.351

Review 6.  Thalassemia Intermedia: Chelator or Not?

Authors:  Yen-Chien Lee; Chi-Tai Yen; Yen-Ling Lee; Rong-Jane Chen
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

Review 7.  Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area.

Authors:  Mohamad H Qari; Yasser Wali; Muneer H Albagshi; Mohammad Alshahrani; Azzah Alzahrani; Ibrahim A Alhijji; Abdulkareem Almomen; Abdullah Aljefri; Hussain H Al Saeed; Shaker Abdullah; Ahmad Al Rustumani; Khoutir Mahour; Shaker A Mousa
Journal:  Orphanet J Rare Dis       Date:  2013-09-17       Impact factor: 4.123

Review 8.  When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.

Authors:  A T Taher; A Radwan; V Viprakasit
Journal:  Vox Sang       Date:  2014-10-07       Impact factor: 2.144

Review 9.  Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives.

Authors:  Karim Bayanzay; Lama Alzoebie
Journal:  J Blood Med       Date:  2016-08-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.